Risk Stratified Randomized Phase III Testing of Blinatumomab in First Relapse of Childhood B-Lymphoblastic Leukemia

Study phase: III

Primary disease category: Leukemia & Lymphoma

Sponsor: Children's Oncology Group

Protocol number: AALL1331

Projected enrollment dates: January 2015 to June 2020

Official study title: Risk Stratified Randomized Phase III Testing of Blinatumomab in First Relapse of Childhood B-Lymphoblastic Leukemia